Arcadia Biosciences, Inc. (RKDA) Financials

RKDA Assets vs Liabilities

DateAssetsLiabilities
Dec. 31, 2025 6.5 million 2.4 million
Sept. 30, 2025 8.6 million 3.1 million
June 30, 2025 7.8 million 3.3 million
March 31, 2025 13.0 million 4.1 million

RKDA Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2025 -861000 17000
Sept. 30, 2025 -257000 53000
June 30, 2025 -2.0 million 86000
March 31, 2025 -1.6 million 117000

RKDA Net Income

No data available :(

RKDA Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2025 4.6 million - -
Sept. 30, 2025 5.9 million - -
June 30, 2025 4.4 million - 11000
March 31, 2025 3.2 million - 21000

RKDA Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Dec. 31, 2025 1.4 million
Sept. 30, 2025 1.4 million
June 30, 2025 1.4 million
March 31, 2025 1.4 million

RKDA Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2025 - - 1.6 million -
Sept. 30, 2025 - - 1.6 million -
June 30, 2025 - 9000 2.1 million -
March 31, 2025 - 13000 1.7 million -

RKDA Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2025 901000 708000
Sept. 30, 2025 1.3 million 884000
June 30, 2025 1.5 million 824000
March 31, 2025 1.2 million 682000

RKDA Revenue by Segment

Graph available only for paid members. Upgrade to see it.

RKDA

Price: $0.98

52 week price:
0.80
6.71

Payout Ratio Range:
-15494.52%
-3.39%

Earnings Per Share: -1.71 USD

Exchange: NCM

Sector: Consumer Defensive

Industry: Packaged Foods

Country: United States

Volume: 191500

Ebitda: -4.4 million

Market Capitalization: 1.6 million

Links: